The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
Open accessAbstract
OBJECT: An important prognostic factor for the surgical outcome and recurrence of a pituitary adenoma is its invasiveness into parasellar tissue, particularly into the space of the cavernous sinus (CS). The aims of this study were to reevaluate the existing parasellar classifications using an endoscopic technique and to evaluate the clinical and radiological outcomes associated with each grade. METHODS: The authors investigated 137 pituitary macroadenomas classified radiologically at least on one side as Grade 1 or higher (parasellar extension) and correlated the surgical findings using an endoscopic technique, with special reference to the invasiveness of the tumor into the CS. In each case, postoperative MRI was performed to evaluate the gross-total resection (GTR) rate and the rate of endocrinological remission (ER) in functioning adenomas. RESULTS: The authors found a 16% rate of CS invasion during surgery for these macroadenomas. Adenomas radiologically classified as Grade 1 were found to be invasive in 1.5%, and the GTR/ER rate was 83%/88%. For Grade 2 adenomas, the rate of invasion was 9.9%, and the GTR/ER rate was 71%/60%. For Grade 3 adenomas, the rate of invasion was 37.9%, and the GTR/ER rate was 75%/33%. When the superior compartment of the CS (Grade 3A) was involved, the authors found a rate of invasion that was lower (p < 0.001) than that when the inferior compartment was involved (Grade 3B). The rate of invasion in Grade 3A adenomas was 26.5% with a GTR/ER rate of 85%/67%, whereas for Grade 3B adenomas, the rate of surgically observed invasion was 70.6% with a GTR/ER rate of 64%/0%. All of the Grade 4 adenomas were invasive, and the GTR/ER rate was 0%. A comparison of microscopic and endoscopic techniques revealed no difference in adenomas with Grade 1 or 4 parasellar extension. In Grade 2 adenomas, however, the CS was found by the endoscopic technique to be invaded in 9.9% and by microscopic evaluation to be invaded in 88% (p < 0.001); in Grade 3 adenomas, the difference was 37.9% versus 86%, respectively (p = 0.002). Grade 4 adenomas had a statistically significant lower rate of GTR than those of all the other grades. In case of ER only, Grade 1 adenomas had a statistically significant higher rate of remission than did Grade 3B and Grade 4 adenomas. CONCLUSIONS: The proposed classification proved that with increasing grades, the likelihood of surgically observed invasion rises and the chance of GTR and ER decreases. The direct endoscopic view confirmed the low rate of invasion of Grade 1 adenomas but showed significantly lower rates of invasion in Grade 2 and 3 adenomas than those previously found using the microscopic technique. In cases in which the intracavernous internal carotid artery was encased (Grade 4), all the adenomas were invasive and the GTR/ER rate was 0%/0%. The authors suggest the addition of Grades 3A and 3B to distinguish the strikingly different outcomes of adenomas invading the superior CS compartments and those invading the inferior CS compartments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844 · cited 1×
“We used the most recent consensus statements 5,6, 25,53 to define ER.”
MethodPituitary Adenomas with Invasion of the Cavernous Sinus Space
Knosp, E., Steiner, E., Kitz, K., & Matula, C. (1993) · Neurosurgery · doi:10.1097/00006123-199310000-00008 · Cited by 1,208
Self-citationThe Declaration of Helsinki and public health
Williams, J. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.08.050955 · Cited by 986
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
A Consensus on Criteria for Cure of Acromegaly
Giustina, A., Chanson, P., Bronstein, M. D., Klibanski, A., Lamberts, S., Casanueva, F. F., Trainer, P., Ghigo, E., Ho, K., & Melmed, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2670 · Cited by 783
Thapar, K., Kovacs, K., Scheithauer, B. W., Stefaneanu, L., Horvath, E., Peter J., P., Murray, D., & Laws, E. R. (1996) · Neurosurgery · doi:10.1097/00006123-199601000-00024 · Cited by 462
Dehdashti, A. R., Ganna, A., Karabatsou, K., & Gentili, F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000297072.75304.89 · Cited by 408
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
Asa, S. L., & Ezzat, S. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0350 · Cited by 388
Endoscopic Endonasal Transsphenoidal Approach: Outcome Analysis of 100 Consecutive Procedures
Cappabianca, P., Cavallo, L. M., Colao, A., Del Basso De Caro, M., Esposito, F., Cirillo, S., Lombardi, G., & de Divitiis, E. (2002) · min - Minimally Invasive Neurosurgery · doi:10.1055/s-2002-36197 · Cited by 343
Meij, B. P., Lopes, M.-B. S., Ellegala, D. B., Alden, T. D., & Laws, E. R. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.2.0195 · Cited by 327
Ammirati, M., Wei, L., & Ciric, I. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303194 · Cited by 302
Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000351007 · Cited by 283
Endoscopic transsphenoidal surgery
Jho, H.-D. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012969719503 · Cited by 280
Losa, M., Mortini, P., Barzaghi, R., Ribotto, P., Terreni, M. R., Marzoli, S. B., Pieralli, S., & Giovanelli, M. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/3/0525 · Cited by 229
Brochier, S., Galland, F., Kujas, M., Parker, F., Gaillard, S., Raftopoulos, C., Young, J., Alexopoulou, O., Maiter, D. M., & Chanson, P. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0255 · Cited by 211
The Role of p53 in Cell Cycle Regulation
Shaw, P. H. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80088-4 · Cited by 169
Molecular screening of pituitary adenomas for gene mutations and rearrangements
Herman, V. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.50 · Cited by 167
Fully Endoscopic Endonasal vs. Transseptal Transsphenoidal Pituitary Surgery
Kabil, M. S., Eby, J. B., & Shahinian, H. K. (2005) · min - Minimally Invasive Neurosurgery · doi:10.1055/s-2005-915635 · Cited by 158
Growth rate of human pituitary adenomas
Landolt, A. M., SHIBATA, T., & Kleihues, P. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.67.6.0803 · Cited by 157
p53 gene mutations in pituitary adenomas: rare events
Levy, A., Hall, L., Yeudall, W. A., & Lightman, S. L. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02797.x · Cited by 150
Classification of pituitary adenomas
Kovács, K., Horváth, É., & Vidal, S. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012945129981 · Cited by 97
Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions
Wolfsberger, S., Ba-Ssalamah, A., Pinker, K., Mlynárik, V., Czech, T., Knosp, E., & Trattnig, S. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.100.2.0278 · Cited by 96
Self-citationLonser, R. R., Ksendzovsky, A., Wind, J. J., et al. (2011) · Journal of neurosurgery · doi:10.3171/2011.8.jns11456 · Cited by 75
Hentschel, S. J., McCutcheon, I. E., Moore, W., & Durity, F. A. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100002614 · Cited by 74
Bonneville, J. F., Cattin, F., Gorczyca, W., & Hardy, J. (1993) · Radiology · doi:10.1148/radiology.187.3.8497646 · Cited by 45
Evaluation and management of the patient with difficult-to-control or resistant hypertension.
Viera, A. J., & Hinderliter, A. L. (2009) · PubMed · Cited by 43
Wolfsberger, S., Kitz, K., Wunderer, J., Czech, T., Boecher-Schwarz, H. G., Hainfellner, J. A., & Knosp, E. (2004) · Acta Neurochirurgica · doi:10.1007/s00701-004-0390-5 · Cited by 22
Self-citationPituitary Adenoma: A Radiotherapeutic Perspective
Platta, C. S., MacKay, C., & Welsh, J. S. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31819d878d · Cited by 18
Cited by
Colao, A., Grasso, L. F. S., Giustina, A., Melmed, S., Chanson, P., Pereira, A. M., & Pivonello, R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0071-6 · Cited by 396
Multidisciplinary management of acromegaly: A consensus
Giustina, A., Barkhoudarian, G., Beckers, A., Ben-Shlomo, A., Biermasz, N., Biller, B., Boguszewski, C., Bolanowski, M., Bollerslev, J., Bonert, V., et al. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09588-z · Cited by 347
Clinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Rusetska, N., Kober, P., Król, S. K., Boresowicz, J., Maksymowicz, M., Kunicki, J., Bonicki, W., & Bujko, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040560 · Cited by 8
Metadata
- Authors
- Micko, A. S. G., Wöhrer, A., Wolfsberger, S., & Knosp, E.
- Venue
- Journal of Neurosurgery
- Published
- 2015-04
- Volume
- 122
- Issue
- 4
- Pages
- 803-811
- ISSN
- 0022-3085 (ISSN-L)
- 1933-0693
- OpenAlex
- W2142504546
- Cited by
- 577
- References
- 29
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.